- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 9, 2025 | 21.06M sh |
| Operating Cash Flow | Q3 2025 · Mar 31, 2025 | −$130K |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | −$4.28M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $7.06M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $1.85M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $3.5M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $2.43M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $3.52M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $4.02M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $8.99M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $3.52M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $20.24M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $15.56M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 17.2M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 16.19M sh |
| Capex | Q3 2025 · Mar 31, 2024 | $19.35K |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $15.09M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $14.8M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $11.22M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.09 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.15 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.09 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.15 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $1.23M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $3.38M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $1.14M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $4.21M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$1.54M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$2.4M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$1.6M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$2.59M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $1.33M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $4.67M |
| Revenue | Q3 2025 · Mar 31, 2024 | $1.9M |
| Revenue | Q3 2025 · Mar 31, 2024 | $7.08M |